<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22-vaccines-08-00307">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Oliphant</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Engle</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nybakken</surname>
    <given-names>G.E.</given-names>
   </name>
   <name>
    <surname>Doane</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Gorlatov</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mehlhop</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Marri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chung</surname>
    <given-names>K.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus</article-title>
  <source>Nat. Med.</source>
  <year>2005</year>
  <volume>11</volume>
  <fpage>522</fpage>
  <lpage>530</lpage>
  <pub-id pub-id-type="doi">10.1038/nm1240</pub-id>
  <?supplied-pmid 15852016?>
  <pub-id pub-id-type="pmid">15852016</pub-id>
 </element-citation>
</ref>
